Cano Health (CANO) Misses Q3 EPS by 8c

Cano Health (NYSE: CANO) reported Q3 EPS of ($0.09), $0.08 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $526.8 million versus the consensus estimate of $440.51 million.

GUIDANCE:

Cano Health sees FY2021 revenue of $2.6-2.7 billion.

For earnings history and earnings-related data on Cano Health (CANO) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Ocean Power Technologies revises fiscal 2026 results after audit
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts